Organon OGN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.12B+104% | $574M-15.0% | $672M-11.9% | $599M-14.9% | $547M-4.9% | ||
| $5.68B-7.1% | $5.76B-7.3% | $5.78B-12.3% | $5.98B-8.7% | $6.12B-7.5% | ||
| $975M+46.6% | $930M+66.4% | $909M+100% | $792M+89.0% | $665M+63.8% | ||
| $4.93B+12.8% | $4.35B+0.1% | $4.7B-1.2% | $4.62B+2.4% | $4.37B+4.2% | ||
| $1.28B+6.9% | $1.3B+11.6% | $1.29B+7.1% | $1.27B+9.0% | $1.2B+1.4% | ||
| $4.15B-11.3% | $4.15B-11.3% | $4.68B+1.7% | $4.68B+1.7% | $4.68B+1.7% | ||
| $1.1B-22.4% | $1.13B-20.1% | $1.34B+75.6% | $1.36B+99.1% | $1.42B+97.4% | ||
| $13B-1.2% | $12.87B-1.8% | $13.55B+6.3% | $13.5B+11.1% | $13.16B+10.6% | ||
| $983M-2.3% | $952M-17.4% | $1.07B-1.6% | $1.07B-14.2% | $1.01B+5.3% | ||
| $16M-20.0% | $16M-20.0% | $45M+350% | $115M+1,178% | $20M+122% | ||
| $2.5B-4.4% | $2.39B-12.1% | $2.68B-4.0% | $2.8B+1.5% | $2.62B+2.8% | ||
| $8.55B-4.3% | $8.63B-2.6% | $8.78B+0.5% | $8.78B+1.5% | $8.94B+2.7% | ||
| $12.09B-4.1% | $12.12B-4.1% | $12.65B+3.2% | $12.77B+6.3% | $12.61B+6.5% | ||
| 500M0.0% | 500M+16,567% | 500M0.0% | 500M0.0% | 500M0.0% | ||
| $1.25B+22.1% | $1.11B+9.8% | $1.32B+35.2% | $1.16B+68.6% | $1.03B+79.1% | ||
| $903M+66.6% | $752M+59.3% | $906M+83.8% | $733M+409% | $542M+1,029% | ||
| $13B-1.2% | $12.87B-1.8% | $13.55B+6.3% | $13.5B+11.1% | $13.16B+10.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Organon cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Organon's balance sheet data come from?
- Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.